JOSEPH T COYLE, M.D.
Psychiatric at Mill St, Belmont, MA
License number
Massachusetts 75163
Category
Psychiatric
Type
Psychiatry
Address
Address
115 Mill St, Belmont, MA 02478
Phone
(617) 855-2101
Organization information
See more information about JOSEPH T COYLE at bizstanding.comJoseph T Coyle
115 Ml St, Belmont, MA 02478
Industry:
Medical Doctor's Office
Doing business as:
Joseph T Coyle MD
Phone:
(617) 855-2101 (Phone)
Medical Doctor, Owners:
Joan Martha Cottler (Social Worker),Joseph Coyle (Medical Doctor, Owner)
Categories:
Psychiatry Physicians
Professional information
Joseph Thomas Coyle, Belmont MA
Specialties:
Psychiatrist
Address:
115 Mill St, Belmont, MA 02478
Education:
Johns Hopkins University, School of Medicine - Doctor of Medicine
National Institutes of Health-Clinical Center - Fellowship - Psychopharmacology
Johns Hopkins Hospital - Residency - Psychiatry
National Institutes of Health-Clinical Center - Fellowship - Psychopharmacology
Johns Hopkins Hospital - Residency - Psychiatry
Board certifications:
American Board of Psychiatry and Neurology Certification in Psychiatry (Psychiatry and Neurology)
Joseph Thomas Coyle, Belmont MA
Specialties:
Psychiatry, Child & Adolescent Psychiatry
Work:
McLean Hospital
115 Mill St, Belmont, MA 02478
115 Mill St, Belmont, MA 02478
Education:
Johns Hopkins University (1969)
Dr. Joseph T Coyle, Belmont MA - MD (Doctor of Medicine)
Specialties:
Neuropsychiatry (Psychiatry)
Address:
Belmont Office
115 Mill St, Belmont 02478
(617) 855-2000 (Phone), (617) 855-3810 (Fax)
115 Mill St, Belmont 02478
(617) 855-2000 (Phone), (617) 855-3810 (Fax)
Certifications:
Psychiatry, 1980
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
Johns Hopkins University / School of Medicine
Graduated: 1969
Johns Hopkins
Nimh
Johns Hopkins University / School of Medicine
Graduated: 1969
Johns Hopkins
Nimh
Methods For Treating Neuropsychiatric Disorders
US Patent:
6420351, Jul 16, 2002
Filed:
Apr 13, 2001
Appl. No.:
09/834351
Inventors:
Guochuan Tsai - Cambridge MA
Joseph Coyle - Belmont MA
Joseph Coyle - Belmont MA
Assignee:
The General Hosptial Corporation - Boston MA
International Classification:
A61K 3166
US Classification:
514114
Abstract:
The invention provides methods for treating neuropsychiatric disorders such as schizophrenia, Alzheimers Disease, autism, depression, benign forgetfulness, childhood learning disorders, close head injury, and attention deficit disorder. The methods entail administering to a patient diagnosed as having a neuropsychiatric disorder a pharmaceutical composition containing (i) a therapeutically effective amount of D- or L-phosphoserine.
Methods For Treating Neuropsychiatric Disorders
US Patent:
6667297, Dec 23, 2003
Filed:
Jul 15, 2002
Appl. No.:
10/196686
Inventors:
Guochuan Tsai - Cambridge MA
Joseph Coyle - Belmont MA
Joseph Coyle - Belmont MA
Assignee:
The General Hospital Corporation - Boston MA
International Classification:
A61K 3166
US Classification:
514119, 514380, 514561
Abstract:
The invention provides methods for treating neuropsychiatric disorders such as schizophrenia, Alzheimers Disease, autism, depression, benign forgetfulness, childhood learning disorders, close head injury, and attention deficit disorder. The methods entail administering to a patient diagnosed as having a neuropsychiatric disorder a pharmaceutical composition containing (i) a therapeutically effective amount of D-alanine (or a modified form thereof), provided that the composition is substantially free of D-cycloserine, and/or (ii) D-serine (or a modified form thereof), and/or (iii) 105 to 500 mg of D-cycloserine (or a modified form thereof), and/or (iv) N-methylglycine (or a modified form thereof).
Methods For Treating Neuropsychiatric Disorders
US Patent:
6228875, May 8, 2001
Filed:
Apr 14, 1999
Appl. No.:
9/291296
Inventors:
Guochuan Tsai - Cambridge MA
Joseph Coyle - Belmont MA
Joseph Coyle - Belmont MA
Assignee:
The General Hospital Corporation - Boston MA
International Classification:
A61K 3142, A61K 31195
US Classification:
514380
Abstract:
The invention provides methods for treating neuropsychiatric disorders such as schizophrenia, Alzheimer's Disease, autism, depression, benign forgetfulness, childhood learning disorders, close head injury, and attention deficit disorder. The methods entail administering to a patient diagnosed as having a neuropsychiatric disorder a pharmaceutical composition containing (i) a therapeutically effective amount of D-alanine (or a modified form thereof), provided that the composition is substantially free of D-cycloserine, and/or (ii) D-serine (or a modified form thereof), and/or (iii) 105 to 500 mg of D-cycloserine (or a modified form thereof), and/or (iv) N-methylglycine (or a modified form thereof).
Methods For Treating Neuropsychiatric Disorders
US Patent:
6974821, Dec 13, 2005
Filed:
Sep 23, 2003
Appl. No.:
10/668583
Inventors:
Guochuan Tsai - Cambridge MA, US
Joseph Coyle - Belmont MA, US
Joseph Coyle - Belmont MA, US
Assignee:
The General Hospital Corporation - Boston MA
International Classification:
A01N043/42
US Classification:
514297, 514319, 514380
Abstract:
The invention provides methods for treating neuropsychiatric disorders such as schizophrenia, Alzheimer's Disease, autism, depression, benign forgetfulness, childhood learning disorders, closed head injury, and attention deficit disorder. The methods entail administering to a patient diagnosed as having a neuropsychiatric disorder a pharmaceutical composition containing (i) a therapeutically effective amount of D-alanine (or a modified form thereof), provided that the composition is substantially free of D-cycloserine, and/or (ii) D-serine (or a modified form thereof), and/or (iii) 105 to 500 mg of D-cycloserine (or a modified form thereof), and/or (iv) N-methylglycine (or a modified form thereof).
Methods For Treating Neuropsychiatric Disorders
US Patent:
7704978, Apr 27, 2010
Filed:
Jul 5, 2005
Appl. No.:
11/175832
Inventors:
Guochuan Tsai - Cambridge MA, US
Joseph Coyle - Belmont MA, US
Joseph Coyle - Belmont MA, US
Assignee:
The General Hospital Corporation - Boston MA
International Classification:
A01N 57/00, A61K 31/42, A61K 31/195
US Classification:
514119, 514380, 514561
Abstract:
The invention provides methods for treating neuropsychiatric disorders such as schizophrenia, Alzheimer's Disease, autism, depression, benign forgetfulness, childhood learning disorders, closed head injury, and attention deficit disorder. The methods entail administering to a patient diagnosed as having a neuropsychiatric disorder a pharmaceutical composition containing (i) a therapeutically effective amount of D-alanine (or a modified form thereof), provided that the composition is substantially free of D-cycloserine, and/or (ii) D-serine (or a modified form thereof), and/or (iii) 105 to 500 mg of D-cycloserine (or a modified form thereof), and/or (iv) N-methylglycine (or a modified form thereof).